[1] YE ZG, ZHANG GP, GAO YH.Research progress in pharmacology of Lianhua Qingwen decoction[J]. Chinese Journal of Experimental Formulas(中国实验方剂学杂志), 2020, 26(22): 181-185. [2] ZHANG LH, YU FR, SANG WT, et al.Research status of Lianhua Qingwen in the treatment of influenza[J]. Chinese Materia Medica and Clinic(中药与临床), 2019, 10(1): 54-58. [3] Yiling pharmaceutical Lianhua Qingwen capsule was approved in Mauritius[J]. Chinese Business(中国商界), 2020(10): 100. [4] LU Y, SHAO DF, SUN Y, et al.The efficacy of Lianhua Qingwen capsule combined with levofloxacin in the treatment of community-acquired pneumonia and its influence on LCQ score and inflammatory factors[J]. Difficult and Difficult Diseases(疑难病杂志), 2020, 19(11): 1152-1156. [5] ZHAO MJ, ZHAO XQ, ZHAO W.Evaluation of the clinical effect of Lianhua Qingwen capsule in the treatment of acute upper respiratory tract infection[J]. Chinese Journal of Hospital Infection(中华医院感染学杂志), 2015, 25(4): 839-841. [6] GAO P, WANG Y, LUO JF, et al.Statistical analysis techniques for evaluating treatment outcome studies based on real-world data[J]. Chinese Journal of Evidence-Based Medicine(中国循证医学杂志), 2019, 19(7): 787-793. [7] SUN LX, LI YY, XIE YM, et al.Clinical characteristics and combined medication rules of 16856 elderly patients who used Suxiao Jiuxin pills in a real-world study[J]. Chinese Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(10): 2335-2342 . [8] ZHU F, HU SJ.Study on the pathogenic characteristics and risk factors of nosocomial lung infections in elderly patients with coronary heart disease and heart failure[J]. Chinese Journal of Preventive Medicine(中国预防医学杂志), 2020, 21(7): 749-753. [9] HE X, QIAN XY, RUAN T.Analysis of causality between cardiovascular disease and other chronic diseases based on Bayesian network[J]. Journal of Zhengzhou University (Medical Edition)[郑州大学学报(医学版)], 2019, 54(4): 512-517 . [10] DENG W, WANG DX.Discussion on clinical teaching of respiratory diseases based on integrated medicine model[J]. Chinese Continuing Medical Education(中国继续医学教育), 2018, 10(30): 42-44. [11] YUE YL.The exploration of integrating medical teaching mode in the teaching of geriatrics[J]. Continuing Medical Education(继续医学教育), 2018, 32(12): 28-30. [12] YANG J, ZHANG R, ZHENG ST, et al.Nursing intervention of winter lung infection in elderly patients hospitalized for a long time[J]. Medical Journal of National Defending Forces in Southwest China(西南国防医药), 2019, 29(9): 974-976. [13] HAO Y, HE J.Analysis of solar terms in 10 common diseases in Beijing area[J]. Chinese Journal of Traditional Chinese Medicine(中华中医药杂志), 2017, 32(3): 1001-1004. [14] PENG LL, LI L, SHEN L, et al.Literature analysis of 175 cases of adverse drug reactions/events caused by Lianhua Qingwen capsules[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(12): 753-755. [15] CHEN Q, QU SS, MENG XL.Lianhua Qingwen capsules induced allergic reactions with liver injury[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2016, 18(5): 396-397. [16] GUOXIAN WJ, HEIN AA, WEIXIANG L, et al.Risk prediction models to guide antibiotic prescribing: a study on adult patients with uncomplicated upper respiratory tract infections in an emergency department[J]. Antimicrobial Resistance & amp; Infection Control, 2020, 9(1): 171-182. [17] SARAH H, TARA L, KL P, et al.Treatment trends and outcomes in healthcare-associated pneumonia[J]. Journal of Hospital Medicine, 2017, 12(11): 886-891. [18] LIU PF, ZHONG ZH, LIU YP.Ambroxol hydrochloride adjuvant treatment of elderly chronic obstructive pulmonary disease with pulmo-nary infection efficacy and adverse drug reaction analysis[J]. Journal of Clinical Rational Use(临床合理用药杂志), 2020, 13(31): 65-66 . [19] CHEN M, LIU Y, FANG F.The effect of Tanreqing injection combined with ambroxol in the treatment of senile encephalopathy with pulmonary infection[J]. Northwest Pharmaceutical Journal(西北药学杂志), 2020, 35(2): 296-299. [20] ZHENG Y, LIN QS, YAN YW, et al.The influencing factors of nosocomial lung infection and the effect of adjuvant treatment of Tanreqing after thoracic surgery[J]. Chinese Journal of Nosocomiology(中华医院感染学杂志), 2020, 30(12): 1870-1874 . [21] WANG L, TAO YL, CHEN WS.Research progress on chemical constituents, pharmacological effects and clinical application of Tanreqing injection[J]. Chinese Herbal Medicine(中草药), 2020(12): 3318-3328. [22] WANG W, TAN J, REN Y, et al.Re-recognizing real-world data research: updates and prospects[J]. Chinese Journal of Evidence-Based Medicine(中国循证医学杂志), 2020, 20(11): 1241-1246. |